Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis

• Main Authors: April W. Armstrong (Author), Andrew F. Alexis (Author), Andrew Blauvelt (Author), Jonathan I. Silverberg (Author), Claire Feeney (Author), Mark Levenberg (Author), Gary Chan (Author), Fan Zhang (Author), Luke Fostvedt (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Early prediction of abrocitinib efficacy in atopic dermatitis (AD) could help identify candidates for an early dose increase. A predictive model determined week 12 efficacy based on week 4 responses in patients receiving abrocitinib 100 mg/day and assessed the effect of an abro...